DNDN

Dendreon Corporation News Headlines

$1.1
*  
0.03
2.65%
Get DNDN Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading DNDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune and Dendreon - Press Releases
11/22/2011 9:30:01 AM - Zacks.com


Biotech Investing Lessons: GILD Buys VRUS - Tactical Trading
11/21/2011 1:00:01 AM - Zacks.com


Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
11/18/2011 11:19:00 AM - Seeking Alpha


Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA Capital
11/18/2011 10:15:00 AM - Seeking Alpha


How To Trade Antares And Dendreon's Whimsical Pop
11/17/2011 2:07:00 PM - Seeking Alpha


IPO Preview: NewLink Genetics
11/8/2011 5:31:00 PM - Seeking Alpha


5 Drugs That Own The Prostate Pipeline
11/8/2011 2:21:00 AM - Seeking Alpha


A Cautionary Tale
11/1/2011 6:54:07 PM - Ted Allrich


Billionaire Steven Cohen's 23 Long Term Stock Picks
10/9/2011 3:30:00 PM - Seeking Alpha


Is The Pain Over For Illumina?
10/9/2011 3:04:00 PM - Seeking Alpha


Real World Costs Impacting Dendreon's Provenge Sales
10/9/2011 8:52:00 AM - Seeking Alpha


Emisphere: Crown Jewel In Oral B12
10/7/2011 9:36:00 AM - Seeking Alpha


Dendreon's Earnings Announcement Has Investors Looking For A Sectorwide Turnaround
10/6/2011 12:55:00 PM - Seeking Alpha


ImmunoCellular Therapeutics: The Biotechnology Moneyball
10/6/2011 8:37:00 AM - Seeking Alpha


Is The Rebound For Real?
10/5/2011 10:32:00 AM - Seeking Alpha


George Soros And Mark Kingdon Are Bullish About These Stocks
10/5/2011 10:03:00 AM - Seeking Alpha


Amid The Turmoil, Keryx Might Be A Great Buy
10/4/2011 2:48:00 PM - Seeking Alpha


Dendreon Revisited: What Management Is Saying About Provenge
10/3/2011 4:00:00 PM - Seeking Alpha


What's Next For Human Genome After The British Roadblock
10/3/2011 1:32:00 PM - Seeking Alpha


8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
10/3/2011 4:39:00 AM - Seeking Alpha


The Dendreon Opportunity: Upside Has Never Looked So Great
10/2/2011 8:44:00 AM - Seeking Alpha


Vical's Allovectin-7: Are The Phase 3 Trial Results Hiding In Plain Sight?
9/30/2011 12:08:00 PM - Seeking Alpha


Wednesday's Big Biotech Losers That Are Poised For Big Rebounds
9/29/2011 12:05:00 PM - Seeking Alpha


8 Underperforming Biotech Stocks Being Bought by the Smart Money
9/24/2011 11:31:00 PM - Seeking Alpha


George Soros' Top 10 Holdings
9/23/2011 6:08:00 PM - Seeking Alpha